196 related articles for article (PubMed ID: 34709700)
1.
Seth N; Seth I; Bulloch G; Siu AHY; Guo A; Chatterjee R; MacManus M; Donnan L
Pediatr Blood Cancer; 2022 Mar; 69(3):e29415. PubMed ID: 34709700
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on
Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K
Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192
[TBL] [Abstract][Full Text] [Related]
3. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
4. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.
Huang T; Li F; Yan Z; Ma Y; Xiong F; Cai X; Zhang Q; Liu F; Dong J
Medicine (Baltimore); 2018 Nov; 97(48):e13457. PubMed ID: 30508968
[TBL] [Abstract][Full Text] [Related]
6.
Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM
Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127
[TBL] [Abstract][Full Text] [Related]
8. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P
Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
Treglia G; Salsano M; Stefanelli A; Mattoli MV; Giordano A; Bonomo L
Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239
[TBL] [Abstract][Full Text] [Related]
11. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.
Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716
[TBL] [Abstract][Full Text] [Related]
13. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of
Liu F; Zhang Q; Zhou D; Dong J
BMC Cancer; 2019 Apr; 19(1):323. PubMed ID: 30953476
[TBL] [Abstract][Full Text] [Related]
15. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
Ruggiero A; Lanni V; Librizzi A; Maurizi P; Attinà G; Mastrangelo S; Giordano A; Riccardi R
J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679
[TBL] [Abstract][Full Text] [Related]
17. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Zhang C; Liang Z; Liu W; Zeng X; Mo Y
BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
[TBL] [Abstract][Full Text] [Related]
19. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
